DBAG mandates GCA for Cleanpart sale

The company generates EBITDA of €13m and expected revenues of €61m in 2017, up from €52m in 2016 and €46m in 2015, according to the Mergermarket report by Fabian Graber.

The GP acquired the company in March 2015, drawing capital from its €700m buyout fund DBAG Fund VI, which held a final close in August 2012. The GP also made a co-investment from its balance sheet, acquiring a 13% stake for €12.5m.

DBAG partially exited its investment in Cleanpart in November 2017, selling the group's healthcare division to Vamed. The division generated approximately 20% of the group's revenues at the time of the divestment.

DBAG Fund VI was more than 86% invested across 11 companies by the end of 2016 and has only made one full realisation, selling Schülerhilfe to Oakley Capital for approximately €300m in May 2017.

DBAG is currently investing from its seventh fund, a €1bn vehicle that held a final close in June 2016 and was 29% deployed by April 2018.

Cleanpart services production tool components, such as memory chips, used in the semiconductor industry. This involves decontaminating, cleaning, coating and, in some cases, replacing the chips. Cleanpart services these components at its own facilities in Germany, France and the US. The company employs 480 people.

DBAG declined to comment. GCA did not return requests for comment.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH
• Industrials
• Deutsche Beteiligungs AG
• GCA Altium